Slap the word "interventional" in front of any description of medicine and all of a sudden it becomes a hot and exciting field worth funding. Indeed, new companies formed to develop minimally invasive technologies to first diagnose, and ultimately treat, breast cancers have attracted more than $130 million recently, and from "A" list venture capital firms.
In breast cancer, the need for less invasive alternatives to surgery is gaping. On the diagnostic side, following routine screening...